Latest Crop Protection News

Nufarm Limited posted a $165.3 million statutory loss for FY25, driven by significant restructuring charges and omega-3 price declines, while announcing a CEO transition effective January 2026.

Nufarm Limited has announced Rico Christensen as its new CEO, effective January 2026, succeeding Greg Hunt who will stay on as advisor until mid-2026. Christensen brings three decades of global agricultural sector expertise and a strong operational focus.

Nufarm reported a mixed FY25 with strong crop protection profits offset by a statutory loss from seed restructuring, while targeting earnings growth and debt reduction in FY26.

Nufarm’s FY25 results reveal robust growth in crop protection and a strategic shift in seed technologies, alongside a significant $538 million reduction in net debt. The company eyes stronger earnings and lower leverage in FY26.

Nufarm Limited reported a $165.3 million statutory loss for FY25, driven by restructuring costs in Seed Technologies despite strong Crop Protection growth. A CEO transition and refinancing moves set the stage for FY26.

Elders Limited reported a robust FY25 with a 12% rise in underlying EBIT to $143.5 million and declared a fully franked final dividend of 18 cents per share. The agribusiness is optimistic about FY26, buoyed by strategic acquisitions and a new divisional model.

Elders Limited reported a solid FY25 with a 12% rise in profit after tax to $50.3 million, completing the strategic acquisition of Delta Agribusiness and advancing key operational and sustainability initiatives.

Bio-Gene Technology’s natural insecticide Qcide® has earned organic listing status from the US Organic Materials Review Institute, marking a pivotal step for its entry into the organic pest control market.

Elders Limited has secured regulatory approval to acquire Delta Agribusiness, subject to divesting six Western Australian branches, while maintaining a positive outlook for FY25 earnings.

DGL Group Limited has issued a corrected FY25 financial presentation, revealing lower EBITDA and NPAT figures due to operational challenges and restructuring costs. Despite revenue growth, the company faces a modified audit opinion on inventory and outlines strategic cost-cutting and growth investments.

DGL Group reported a 4% revenue increase to $481.5 million in FY25, but underlying profits took a hit due to operational losses and restructuring costs. The company is investing heavily in growth and system integration to drive future efficiency.

Bio-Gene Technology Limited reported a net loss of AUD 2.58 million for FY2025 while making significant strides in developing its bio-insecticides Flavocide and Qcide, securing US Department of Defense grants and expanding global partnerships.